Healthcare Nanotechnology (Nanomedicine) Market Size | Global Industry Growth Report, 2027
Global Healthcare Nanotechnology (Nanomedicine) Market to reach USD 482.99 billion by 2027. Global Healthcare Nanotechnology (Nanomedicine) Market is valued approximately USD 196.47 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11.9 % over the forecast period 2020-2027. Healthcare Nanotechnology (Nanomedicine) is the product which is nano-formulations of the existing drugs or new drugs or nanomaterials.
Nanomedicine helps in improving human health by providing solutions for various life-threatening diseases, like cancer, Parkinson's disease, Alzheimer's disease, diabetes, orthopedic diseases, and infections blood, lungs, and cardiovascular system. For instance: according to the Alzheimer's Disease International, there were around 50 million people globally with dementia in 2020, which is expected to double every 20 years. According to the Globocan 2020, the global cancer burden increased to 19.3 million cases and 10 million cancer deaths in 2020. This will increase the demand for effective nanomedicines in the management of the diseases.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/3357902/
Further, increasing investments in urgent care, increasing geriatric population and strategic development between hospitals and the manufacturers has led the adoption of Healthcare Nanotechnology (Nanomedicine) across the forecast period. The market has seen positive growth due to investments in new products by research & development. For Instance: in 2020, Medtronic PLC launched navigated titanium spinal implant, its new Adaptix Interbody System which is with the Titan nanoLOCK Surface Technology. In 2019, Nanobiotix, a clinical stage nanomedicine company had obtained the CE approval for its Hensify (NBTXR3), nanoparticles designed for injection directly into a tumor. However, stringent regulatory issues and high cost of nano-medicines compared to the traditional medicines along with low awareness among consumers in low income countries impedes the growth of the market over the forecast period of 2020-2027. Also, with the increasing prevalence of diseases, technological advancements for early disease diagnosis & preventive intervention the adoption & demand for Healthcare Nanotechnology (Nanomedicine) is likely to increase.
The regional analysis of global Healthcare Nanotechnology (Nanomedicine) market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing geriatric population and promptness & affordability of nano-medicines coupled with the well-established healthcare infrastructure along with the huge investments in research & development activities. For instance: according to the www.acc.org, in 2018, coronary heart disease was the leading cause of deaths attributable to cardiovascular disease in the United States with 43.8% of total CVD deaths. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rise in research grants, increasing venture capital investors from developing economies of this region and increasing international research collaborations along with the improving healthcare infrastructure would create lucrative growth prospects for the Healthcare Nanotechnology (Nanomedicine) market across Asia-Pacific region.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
To access a sample pages of this report titled “Global Healthcare Nanotechnology (Nanomedicine) Market Size study, by Diseases (Cardiovascular Diseases, Oncological Diseases, Neurological Diseases and Others), Application (Drug Delivery, Biomaterials, Active Implants and Others) and Regional Forecasts 2020-2027” in detail along with the table of contents, please click the link below: https://www.marketstudyreport.com/reports/global-healthcare-nanotechnology-nanomedicine-market-size-research
Healthcare Nanotechnology (Nanomedicine) Market By Diseases:
- Cardiovascular Diseases
- Oncological Diseases
- Neurological Diseases
Healthcare Nanotechnology (Nanomedicine) Market By Application:
- Drug Delivery
- Active Implants
Healthcare Nanotechnology (Nanomedicine) Market By Region:
- North America
Major market player included in this report are:
- Abbott Laboratories
- CombiMatrix Corporation
- GE Healthcare
- Sigma-Tau Pharmaceuticals, Inc.
- Johnson & Johnson
- Mallinckrodt plc
- Merck & Company, Inc.
- Nanosphere, Inc.
- Pfizer, Inc.
- Celgene Corporation
Global Nanotechnology Market Size study, by type, By Application and Regional Forecasts 2020-2027
Global Nanotechnology Market to reach USD 2591.50 million by 2027. Global Nanotechnology Market is valued approximately USD 1165.90 million in 2019 and is anticipated to grow with a healthy growth rate of more than 10.50% over the forecast period 2020-2027. Nanoscience and nanotechnology are the study of devices and nanoparticles which find their application across all science fields such as bio-medical, chemical, mechanics and materials sciences. Also, nanotechnology carries a significant impact and served as a revolutionary and beneficial technology across various industrial domains including medicine, energy, transportation, material & manufacturing and consumer products.
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.
Market Study Report LLC
Toll Free: 1-866-764-2150